Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation
Clinical trial NCT03053180 · COMPLETED
Trial details
- NCT number
- NCT03053180
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-20
- Primary completion
- 2017-12-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.